Unfolding the role of calreticulin in myeloproliferative neoplasm pathogenesis

TR Merlinsky, RL Levine, E Pronier - Clinical Cancer Research, 2019 - AACR
In 2013, two seminal studies identified gain-of-function mutations in the Calreticulin (CALR)
gene in a subset of JAK2/MPL-negative myeloproliferative neoplasm (MPN) patients. CALR …

[HTML][HTML] Unfolding the Role of Calreticulin in Myeloproliferative Neoplasm Pathogenesis

TR Merlinsky, RL Levine, E Pronier - Clinical cancer research: an …, 2019 - ncbi.nlm.nih.gov
In 2013, two seminal studies identified gain of function mutations in the Calreticulin (CALR)
gene in a subset of JAK2/MPL-negative myeloproliferative neoplasm (MPN) patients. CALR …

Unfolding the Role of Calreticulin in Myeloproliferative Neoplasm Pathogenesis

TR Merlinsky, RL Levine… - … cancer research: an …, 2019 - pubmed.ncbi.nlm.nih.gov
In 2013, two seminal studies identified gain-of-function mutations in the Calreticulin (CALR)
gene in a subset of JAK2/MPL-negative myeloproliferative neoplasm (MPN) patients. CALR …

Unfolding the Role of Calreticulin in Myeloproliferative Neoplasm Pathogenesis.

TR Merlinsky, RL Levine, E Pronier - Clinical Cancer Research: an …, 2019 - europepmc.org
In 2013, two seminal studies identified gain of function mutations in the Calreticulin (CALR)
gene in a subset of JAK2/MPL-negative myeloproliferative neoplasm (MPN) patients. CALR …

Unfolding the Role of Calreticulin in Myeloproliferative Neoplasm Pathogenesis

TR Merlinsky, RL Levine, E Pronier - Clinical Cancer Research, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> In 2013, two seminal studies identified gain-of-
function mutations in the Calreticulin (CALR) gene in a subset of JAK2/MPL-negative …